explore -WSS

explore

author：focus 2025-10-01 18:44:05 - browse：4715

When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

“If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Cybersecurity threat forces Lurie Children's to take systems offline

explore

focus

WSS

Vertex non

Grail faces three suits alleging harassment, retaliation

ARCH Venture Partners is raising $3 billion for a life sciences fund

Covid misinformation case heads to Supreme Court

Some dementia cases could be undiagnosed liver disease

Woodcock on FDA’s accelerated approval and her next chapter

hotspot

explore

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

Can CDC director Mandy Cohen drive consensus in Washington?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Juul spent big to court Black leaders to promote its e

Apple is now the first public company to be valued at $3 trillion

Involuntary treatment for addiction doesn't work

As demand for Covid shots wanes, Moderna seeks its next success

Cybersecurity threat forces Lurie Children's to take systems offline

Alkermes shareholders re

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

hotspot

The new HIV moral panic

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Vertex non

Celiac disease study examines precisely how gluten triggers injury

New Ultima Genomics DNA sequencer can read genome for $100

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

hotspot

explore

focus

hotspot